Management of Alcoholic Ascites with Jaundice

Initial Diagnostic Workup

• Patients with alcoholic ascites and jaundice require immediate diagnostic paracentesis, infection screening, severity assessment, and supportive care to reduce the 40-50% 90-day mortality risk associated with alcoholic hepatitis 1, 2
• The American Association for the Study of Liver Diseases recommends a complete blood count with differential to look for neutrophilia, which is common in alcoholic hepatitis 1
• Liver function tests, including AST and ALT, should be performed, with AST typically 2-6 times the upper limit and an AST/ALT ratio >1.5 3
• Serum bilirubin levels should be checked, with >3.0 mg/dL indicating severe alcoholic hepatitis 1
• Renal function tests, including BUN and creatinine, should be performed to assess for hepatorenal syndrome 1, 2

Severity Assessment

• The Maddrey Discriminant Function (MDF) should be calculated, with MDF >32 indicating severe alcoholic hepatitis with high 28-day mortality 1, 2
• The MELD score should be calculated, with MELD >20 predicting high 90-day mortality 1, 2

Initial Management

• The American College of Gastroenterology recommends infection control, including obtaining cultures of blood, urine, and ascites, regardless of fever presence 1, 2
• Empiric antibiotics, such as third-generation cephalosporin, should be started immediately if spontaneous bacterial peritonitis is suspected 4
• Fluid and electrolyte management, including therapeutic paracentesis and sodium restriction, should be initiated 5, 4
• The European Association for the Study of the Liver recommends diuretic therapy, including spironolactone and furosemide, to manage ascites 4

Special Considerations

• The American Association for the Study of Liver Diseases recommends assessing for alcohol withdrawal and treating if present 6
• Thiamine supplementation should be provided to prevent Wernicke's encephalopathy 6
• Adequate nutrition, including 1-1.5g protein/kg/day and 30-40 kcal/kg/day, should be ensured 1, 6
• The American College of Gastroenterology recommends monitoring for hepatorenal syndrome and avoiding nephrotoxic drugs, including NSAIDs 1, 2

Disposition

• Patients with severe alcoholic hepatitis, evidence of infection, hepatic encephalopathy, or renal dysfunction should be admitted to the hospital 1, 2, 6
• Early liver transplantation evaluation should be considered for appropriate candidates with MELD >26 2, 6

Guideline Recommendations for Ascites Evaluation and Management in Severe Alcoholic Hepatitis

Diagnostic Paracentesis

• Perform bedside diagnostic paracentesis immediately and send ascitic fluid for cell count with differential, total protein, albumin, and culture in blood‑culture bottles before initiating antibiotics. 7

Ascitic Fluid Interpretation

• Calculate the serum‑ascites albumin gradient (SAAG); a SAAG ≥ 1.1 g/dL confirms portal‑hypertension‑related ascites (cirrhosis). 7

Laboratory Monitoring

• Check serum electrolytes, specifically sodium (to identify hyponatremia) and potassium, as part of the initial work‑up. 8

Therapeutic Paracentesis and Albumin Replacement

• When large‑volume (4–6 L) therapeutic paracentesis is required, replace albumin at 8 g per liter removed if more than 5 L are extracted. 7

Sodium Restriction

• Implement a dietary sodium limit of 2,000 mg/day (≈ 88 mmol/day) to aid ascites mobilization. 7

Diuretic Therapy for Recurrent Ascites

• If diuretics are initiated (after assessing renal function), use a combination of spironolactone 100 mg plus furosemide 40 mg daily. 8

Protein Management in Hepatic Encephalopathy

• Do not restrict dietary protein even when overt hepatic encephalopathy is present, as protein restriction worsens outcomes. 9

Prognostic Significance of Hepatic Encephalopathy

• Overt hepatic encephalopathy is associated with the highest mortality among decompensated cirrhosis complications. 9

Avoidance of Non‑Beneficial Tests

• Do not order serum CA‑125 testing in patients with ascites, because it is nonspecific and may lead to unnecessary investigations. 7

Fluid Management Principles

• Do not impose fluid restriction; focus on sodium restriction to promote ascites mobilization. 7

Contraindicated Pharmacologic Agents

• Avoid disulfiram in this patient population due to its hepatotoxic potential. 9